Top Buy
| Security | Buy | Sell ▲ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Davita Inc. | 2 | 0 | 0 | 0 | €124.95 | €124.89 | -0.050% |
| Exelixis Inc. | 18 | 0 | 3 | 0 | €20.62 | €26.01 | 26.122% |
| Neurocrine Bioscience | 27 | 0 | 7 | 0 | €130.70 | €140.34 | 7.376% |
| Tenet Healthcare | 28 | 0 | 7 | 0 | €112.00 | €121.67 | 8.631% |
| Catalent Inc. | 2 | 0 | 0 | 0 | €52.32 | €55.00 | 5.122% |
| Repligen Corp. | 13 | 0 | 1 | 0 | €155.15 | €184.76 | 19.085% |
| Alnylam Pharmace. | 36 | 0 | 3 | 0 | €141.60 | €228.30 | 61.229% |
| Halozyme Therapeutics Inc. | 13 | 0 | 2 | 0 | €37.15 | €53.50 | 43.998% |
| Insulet Corp. | 14 | 0 | 1 | 0 | €162.10 | €215.54 | 32.966% |
| Agios Pharmaceuticals Inc. | 5 | 0 | 2 | 0 | €30.60 | €38.99 | 27.414% |
| West Pharmaceutical Services Inc. | 6 | 0 | 0 | 0 | €339.10 | €369.72 | 9.031% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €365.20 | €421.61 | 15.445% |
| Ensign Group Inc. | 8 | 0 | 1 | 0 | €109.00 | €116.50 | 6.877% |
| United Therapeutics | 18 | 0 | 3 | 0 | €243.70 | €288.66 | 18.449% |
| Merit Medical Systems | 16 | 0 | 5 | 0 | €70.50 | €86.90 | 23.258% |
| Select Medical Holdings | 5 | 0 | 3 | 0 | €26.00 | €36.31 | 39.673% |
| Haemonetics Corp. | 7 | 0 | 1 | 0 | €84.50 | €97.90 | 15.860% |
| Blueprint Medicines Corp | 1 | 0 | 1 | 0 | €99.52 | - | - |
| Integer Hldg | 1 | 0 | 0 | 0 | €101.00 | - | - |
| Amedisys Inc. | 13 | 0 | 0 | 0 | €84.00 | €92.26 | 9.833% |
| Icu Medical Inc. | 3 | 0 | 0 | 0 | €90.50 | €124.85 | 37.953% |
| Bio-Techne Corp. | 10 | 0 | 2 | 0 | €72.00 | €75.94 | 5.467% |
| Healthequity Inc. | 1 | 0 | 0 | 0 | €73.50 | €79.00 | 7.483% |
| Charles River Labs Intl | 9 | 0 | 0 | 0 | €216.90 | €247.61 | 14.157% |
| Xencor Inc. | 9 | 1 | 1 | 0 | €18.70 | €31.74 | 69.727% |